SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc, zoomboom
Search This Board: 
Last Post: 5/26/2017 1:51:02 PM - Followers: 688 - Board type: Free - Posts Today: 0

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.

 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.

ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in FacebookTwitter, LinkedIn & Google+
 
                                                                                       


 

NEWS



Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 

ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3
 
 
 

 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111

 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 

info@amarantus.com
pr@amarantus.com


Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com



IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475

ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 

 
 
                                                                            

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS
Current Price
Volume:
Bid Ask Day's Range
AMBS News: Statement of Changes in Beneficial Ownership (4) 05/15/2017 12:09:57 PM
AMBS News: Current Report Filing (8-k) 05/09/2017 04:17:24 PM
AMBS News: Statement of Changes in Beneficial Ownership (4) 05/05/2017 04:58:34 PM
AMBS News: Current Report Filing (8-k) 04/17/2017 04:29:46 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 04/06/2017 09:03:57 AM
PostSubject
#126308   congrats getting an update from IR would be good JPetroInc 05/25/17 06:42:17 AM
#126307   Yes, that's correct. $AMBS jjr04001 05/24/17 11:53:28 PM
#126306  Restored all $300 worth? JPetroInc 05/24/17 05:16:56 PM
#126305   Bought some more at .041 $AMBS jjr04001 05/24/17 10:16:07 AM
#126304   last me I checked 2 weeks ago, Gerald JPetroInc 05/24/17 09:53:19 AM
#126302   with the resignations of Con Flannigan & Robert Trapp JPetroInc 05/22/17 02:32:11 PM
#126301   Why can't Gerald close on a mere $2.5-Mil. JPetroInc 05/20/17 11:40:17 AM
#126299  Restored ESS article is much older than 5/17/17 JPetroInc 05/18/17 08:55:01 PM
#126298   smart ones already bailed yesterday JPetroInc 05/18/17 08:43:00 PM
#126295   or better yet, how about calling Gerald direct JPetroInc 05/18/17 03:09:32 PM
#126293   You should hold on with your comments myersvodka 05/18/17 12:24:28 PM
#126292   L-2 Real-Time JPetroInc 05/18/17 08:56:46 AM
#126291   Gerald whose in charge of this dumpfest ??? JPetroInc 05/17/17 10:17:44 PM
#126289   the amount of 1-day sells is disturbing JPetroInc 05/17/17 02:08:27 PM
#126288   no electronic program trading involved with this sheet JPetroInc 05/17/17 12:12:43 PM
#126287   Program selling. willlbone 05/17/17 11:49:43 AM
#126286   I called SeD office in Maryland listed on JPetroInc 05/17/17 06:42:16 AM
#126285   Gerald and Gerald alone needs to close the JPetroInc 05/16/17 12:52:29 PM
#126283   AMBS HQ main tele #415-688-4484 disconnected JPetroInc 05/16/17 10:10:28 AM
#126281   Obviously this isn't good news at all. It SidVicious 05/16/17 09:08:15 AM
#126280   Conn Flanigan resigns as AMBS BOD - 5/15/17 JPetroInc 05/15/17 04:38:20 PM
#126279   "revenue for LymPro will change math" JPetroInc 05/14/17 05:04:58 PM
#126278  Restored LymPro revenue will change math JPetroInc 05/13/17 08:46:41 PM
#126277   They uplisted? joboggi 05/13/17 04:00:26 PM
#126276   "Shelly - we're uplisting from strength" JPetroInc 05/12/17 11:20:36 PM
#126275   Well he either ran away or abandoned ship. joboggi 05/12/17 10:27:06 PM
#126274   Gerald ran away & abandoned ship JPetroInc 05/11/17 01:40:03 PM
#126273   In the event that creditors and certain other joboggi 05/11/17 10:46:03 AM
#126272   where is the $2.5-Mil. in requisite LOI funding JPetroInc 05/11/17 09:29:56 AM
#126271   need confirmation that AMBS can actually obtain $2.5-Mil JPetroInc 05/11/17 02:44:16 AM
#126270   UPDATE REGARDING THE LETTER OF INTENT JPetroInc 05/10/17 07:57:48 PM
#126269   L2 - 0.0410 (6.29%) JPetroInc 05/10/17 03:51:08 PM
#126267   Wei is off the BOD but remains as CFO JPetroInc 05/09/17 09:23:24 PM
#126266   And Mr. Wei Grundle 05/09/17 04:51:50 PM
#126265   the more I dig into Gerald's henious and JPetroInc 05/09/17 02:05:45 PM
#126262   On May 3, 2017, Mr. Robert H. Trapp JPetroInc 05/05/17 07:59:53 PM
#126261   won't touch this with conversions in-play: JPetroInc 05/04/17 04:30:20 PM
#126260   Looking like a good add here $AMBS jjr04001 05/04/17 02:59:16 PM
#126259   need confirmation that AMBS can actually obtain $2.5-Mil JPetroInc 05/03/17 02:43:23 PM
#126258   Chart still looks good. No holding though joboggi 05/03/17 12:04:48 PM
#126256   I know, they can sell stock joboggi 05/02/17 05:48:20 PM
#126255   unfortunately, this is and will remain "dead money" JPetroInc 04/27/17 12:33:04 PM
#126254   655 Montgomery St. Suite 900 in San Francisco JPetroInc 04/27/17 09:27:58 AM
#126253   do they even have a facility they need Inoviorulez 04/26/17 10:28:47 PM
#126252   end of month sell off JPetroInc 04/26/17 10:22:59 AM
#126251   just may see my name next to BCM JPetroInc 04/25/17 08:04:11 PM
#126250   Well if your goal is to inform, then Inoviorulez 04/25/17 06:47:41 PM
#126249   Even though it may be limited - they're JPetroInc 04/25/17 01:44:25 PM
#126248   The chart may look pretty good to you jugs 04/25/17 01:16:33 PM
#126247   AMBS management and their financial cohorts have to JPetroInc 04/25/17 11:27:18 AM
PostSubject